Obsidian Therapeutics, Inc. Common Stock (OBX) is a publicly traded the market company. As of November 7, 2026, OBX trades at $13.35 with a market cap of $593.02M and a P/E ratio of 0.00. OBX moved +44.74% today. Year to date, OBX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $9.60 to $49.97. Analyst consensus is strong buy with an average price target of $40.00. Rallies surfaces OBX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for OBX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $13.35 |
| Market Cap | $593.02M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.97 |
| 52-Week Low | $9.60 |
| Volume | 2.05M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover OBX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.00.